Dabigatran Assay




Test Mnemonic

DBGTRN

CPT Codes

  • 80299 - QTY (1)

LOINC ®

68980-2

Aliases

  • Pradaxa

Performing Laboratory

Cleveland Clinic Laboratories


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
2 mLPlasmaSodium citrate (Lt. Blue) Frozen 

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
2 mL     

Stability

Environmental Condition Description
Ambient4 hours
RefrigeratedUnacceptable
Frozen4 weeks

Days Performed

Sun - Sat

Turnaround Time

4 hours

Methodology

Name Description
Chromogenic 

Reference Range

Dabigatran
Sex Age From Age To Type Range Range Unit
       Dose and Regimen: 150 mg bid; Peak: 175 (117 - 275) ng/mL 
       Dose and Regimen: 150 mg bid; Trough: 91 (61 - 143) ng/mL 

Special Info

Peak: 2 hours after dose; Trough: 12 hours after dose

Clinical Info

Dabigatran etexilate is a novel, orally administered direct thrombin inhibitor. It has proved effective for treating and preventing venous thromboembolism, preventing stroke in patients with atrial fibrillation, and treating myocardial infarct. It can be used to prevent hemorrhagic and thromboembolic complications associated with long term anticoagulation with warfarin. As an active form, dabigatran is a potent, competitive and reversible direct inhibitor of the active site of thrombin with a half life of approximately 12 hours. Dabigatran will be measured by chromogenic anti-IIa assay using specific Aniara Dabigatran calibrator performed on the STA-R Evolution coagulometer.